Invited Speaker

Abstract: The present study was designed to explore the short-term therapeutic effect of camel milk (CM) compared to buffalo milk (BM) in Alloxan® induced diabetes in rabbits. Twenty-five female rabbits were divided into five groups (n=5); Placebo (G1), diabetic groups (Alloxan® injected intravenously) including diabetic control (G2), CM @ 40ml/kg (G3), BM@40ml/kg (G4) and glibenclamide (Glicon®) @10mg/kg (G5) orally for 59 days. Blood and serum samples were taken for hematology and biochemical analysis. Kidney and liver tissues were processed by routine paraffin technique. Histologic sections were evaluated for diabetes-induced degenerative changes and antidiabetic effect of camel and buffalo milk. Diabetes showed significant (P≤0.05) impact on all parameters observed in the present study. Camel milk significantly (P≤0.05) recovered diabetic altered hematological (RBC, MCV, Hb, MCH) and serological parameters (AST, ALT, creatinine, BUN, TPs, and TOS). Camel milk and glibenclamide therapy showed more significant (P<<0.01) reduction in blood glucose level as compared to buffalo milk. Microscopic observations demonstrated that camel milk and glibenclamide improved the altered histology of liver and kidneys towards normal. Hence the present work confirms the hypoglycemic effect of CM as well as marked improvement in kidneys and liver function,which was greater than BM fed group.The results indicate that CM have a potential therapeutic effect in the treatment of hyperglycemia and play a significant role in its management as well as reduces the risk of diabetes-related complications.

Biography: Dr. Anas Sarwar Qureshi is a renowned biomedical scientist with 33 years of teaching, research and management experience AT University level. He is a veterinary graduate from the University of Agriculture, Faisalabad, Pakistan and has PhD from the Hanover University Germany. He is a recipient of the fellowships for postdoc studies from the Alexander von Humboldt Foundation and German Academic Exchange Program (DAAD) in Bonn and Berlin Universities of Germany. He is also holder of the Endeavour Executive Fellowship from the Macquarie University of Sydney, Australia, where he worked on the "Development of new treatments for brain arteriovenous malformations: molecular responses to radiation in vitro and in vivo models" in collaboration with the Neurosurgery Department of the Australian School of Advanced Medicine. His most recent passion has been "the amniotic membrane-derived mesenchymal stem cells and platelet-rich plasma; a potential source for in vitro endometrial stromal cells proliferation in buffalo (Bubalis bubalis)" in collaboration with Afyon Kocatepe University, Turkey.

He is author of more than 200 scientific publications in English and German including 75impact factor papers, more than 100 review articles; 5 books as major author/editor of several chapters in internationally published books. He has supervised 7 PhD and 80 MPhil/MSc Hons candidates in anatomy and allied sciences. Currently, he is supervising 4 PhD and numerous master students.

Prof. Qureshi has traveled to over 35 countries to participate in international conferences, seminars and discussion forums where he has delivered lectures and keynote addresses on different aspects of veterinary and animal sciences. He has been instrumental in organizing several international conferences, workshops and seminars. He is Editor of the "International Journal of Human Anatomy (JHUA)"and member of the editorial boards of Pakistan Veterinary Journal, Ecronicon J Vet. Sci. (UK), and Ruminant Science (India) and a regular reviewer of several journals. Currently, he is serving as Professor/Chairman Department of Anatomy, University of Agriculture, Faisalabad, Pakistan.